Inventor · disambiguated record
Bo Liu
Also filed as: LIU BO · LIU BO-JUN
68 granted patents·37 pending applications·257 citations·filing 2003–2024
98Inventor score
Files withGENSUN BIOPHARMA INC11MICROSOFT TECHNOLOGY LICENSING LLC10ABBVIE SARL9ABBVIE OVERSEAS SARL6CARROLL WILLIAM A6
Top patents by PatentIndex Score
105 records- 0196US9981910B2Substituted pyrrolidines and methods of useABBVIE SARL·Filed 2017·Granted May 29, 2018·31 cites·23 claims
- 0295US11132113B1Interaction signal processing in distributed computing systemsMICROSOFT TECHNOLOGY LICENSING LLC·Filed 2020·Granted Sep 28, 2021·4 cites·20 claims
- 0395US10118916B2Modulators of cystic fibrosis transmembrane conductance regulator proteinABBVIE SARL·Filed 2017·Granted Nov 6, 2018·30 cites·50 claims
- 0492US10537637B2Checkpoint regulator antagonistsGENSUN BIOPHARMA INC·Filed 2017·Granted Jan 21, 2020·5 cites·8 claims
- 0591US11518813B2Trispecific antagonistsGENSUN BIOPHARMA INC·Filed 2020·Granted Dec 6, 2022·2 cites·14 claims
- 0691US10647773B2Trispecific antagonistsGENSUN BIOPHARMA INC·Filed 2019·Granted May 12, 2020·4 cites·15 claims
- 0791US9642831B2Substituted chromanes and method of useABBVIE S Á R L·Filed 2015·Granted May 9, 2017·7 cites·69 claims
- 0890US8492371B2Compounds as cannabinoid receptor ligandsCARROLL WILLIAM A·Filed 2010·Granted Jul 23, 2013·18 cites·17 claims
- 0990US8173687B2Compounds as cannabinoid receptor ligandsCARROLL WILLIAM A·Filed 2009·Granted May 8, 2012·18 cites·16 claims
- 1089US11001635B2Antitumor antagonistsGENSUN BIOPHARMA INC·Filed 2019·Granted May 11, 2021·2 cites·4 claims
- 1188US10462239B1Flexible units for experimentationMICROSOFT TECHNOLOGY LICENSING LLC·Filed 2016·Granted Oct 29, 2019·10 cites·12 claims
- 1288US8288428B2Compounds as cannabinoid receptor ligandsWANG XUEQING·Filed 2010·Granted Oct 16, 2012·17 cites·13 claims
- 1388US8236822B2Compounds as cannabinoid receptor ligandsWANG XUEQING·Filed 2010·Granted Aug 7, 2012·17 cites·20 claims
- 1487US8883993B2Tetraselmis promoters and terminators for use in eukaryotic cellsEXXONMOBIL RES & ENG CO·Filed 2012·Granted Nov 11, 2014·10 cites·30 claims
- 1586US11517623B2Anti-PD-1 antibodies, antigen-binding portions thereof and checkpoint regulator antogonists comprising the sameGENSUN BIOPHARMA INC·Filed 2019·Granted Dec 6, 2022·1 cites·17 claims
- 1685US9452986B26-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of useABBVIE INC·Filed 2015·Granted Sep 27, 2016·5 cites·27 claims
- 1784US10399940B2Substituted pyrrolidines and methods of useABBVIE SARL·Filed 2017·Granted Sep 3, 2019·4 cites·21 claims
- 1884US7888374B2Inhibitors of c-jun N-terminal kinasesABBOTT LAB·Filed 2006·Granted Feb 15, 2011·9 cites·23 claims
- 1983US7640502B2Presentation facilitationMICROSOFT CORP·Filed 2004·Granted Dec 29, 2009·20 cites·31 claims
- 2082US12350333B2Checkpoint regulator antagonistsGENSUN BIOPHARMA INC·Filed 2022·Granted Jul 8, 2025·0 cites·16 claims
- 2182US10428017B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE SARL·Filed 2018·Granted Oct 1, 2019·1 cites·19 claims
- 2282US9969693B26-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of useABBVIE INC·Filed 2016·Granted May 15, 2018·3 cites·11 claims
- 2382US8542324B2Efficient image and video recoloring for colorblindnessWANG MENG·Filed 2010·Granted Sep 24, 2013·5 cites·16 claims
- 2481US9567322B2Substituted tetrahydropyrans and method of useABBVIE S Á R L·Filed 2015·Granted Feb 14, 2017·4 cites·98 claims
- 2579US10988454B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2018·Granted Apr 27, 2021·1 cites·1 claims
- 2679US9840513B2Substituted tricyclics and method of useABBVIE S À R L·Filed 2016·Granted Dec 12, 2017·3 cites·68 claims
- 2778US11945873B2Antitumor antagonistsGENSUN BIOPHARMA INC·Filed 2021·Granted Apr 2, 2024·0 cites·6 claims
- 2878US11030772B2Pose synthesisMICROSOFT TECHNOLOGY LICENSING LLC·Filed 2019·Granted Jun 8, 2021·3 cites·18 claims
- 2978US10894823B2Trispecific inhibitors for cancer treatmentGENSUN BIOPHARMA INC·Filed 2017·Granted Jan 19, 2021·1 cites·7 claims
- 3078US7115767B2Tetraline derivatives as ghrelin receptor modulatorsABBOTT LAB·Filed 2004·Granted Oct 3, 2006·9 cites·21 claims
- 3175US11851493B2Trispecific antagonistsGENSUN BIOPHARMA INC·Filed 2020·Granted Dec 26, 2023·0 cites·20 claims
- 3274US8748127B2Truncated L1 protein of human papillomavirus type 6LI SHAOWEI·Filed 2008·Granted Jun 10, 2014·2 cites·14 claims
- 3373US11620526B2Sensitivity classification neural networkMICROSOFT TECHNOLOGY LICENSING LLC·Filed 2022·Granted Apr 4, 2023·0 cites·20 claims
- 3473US9745351B2Truncated L1 protein of human papillomavirus type 6UNIV XIAMEN·Filed 2014·Granted Aug 29, 2017·2 cites·15 claims
- 3572US2021238159A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE OVERSEAS SARL·Filed 2021·Application pending·0 cites
- 3671US10844042B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 24, 2020·0 cites·2 claims
- 3771US10844041B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 24, 2020·0 cites·2 claims
- 3871US10829473B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 10, 2020·0 cites·2 claims
- 3971US8101669B2Exchange membrane containing modified maleimide oligomersPAN JING-PIN·Filed 2007·Granted Jan 24, 2012·2 cites·18 claims
- 4070US10597453B2Antitumor immune checkpoint regulator antagonistsGENSUN BIOPHARMA INC·Filed 2019·Granted Mar 24, 2020·0 cites·14 claims
- 4170US10570141B2Substituted pyrrolopyrimidine CDK inhibitor, pharmaceutical composition containing same and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Feb 25, 2020·1 cites·20 claims
- 4269US10981890B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Apr 20, 2021·0 cites·1 claims
- 4369US8895592B2Compounds as cannabinoid receptor ligandsFROST JENNIFER M·Filed 2009·Granted Nov 25, 2014·2 cites·12 claims
- 4468US2025160308A1Nucleic acid construct based on cre-loxp and crispr and use thereofUNIV SHANGHAI TECHNOLOGY·Filed 2023·Application pending·0 cites
- 4567US12461938B2Exporting customer data using a compliant tenant shardMICROSOFT TECHNOLOGY LICENSING LLC·Filed 2024·Granted Nov 4, 2025·0 cites·20 claims
- 4667US10844098B2Method for preparing bacterial polysaccharide-modified recombinant fusion protein and use of the proteinINST OF BIOTECHNOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES CHINA·Filed 2015·Granted Nov 24, 2020·2 cites·11 claims
- 4767US9626064B2Presentation facilitationXU YING-QING·Filed 2009·Granted Apr 18, 2017·0 cites·20 claims
- 4864US2022325238A1Wnt compositions and methods for serum-free synthesisUNIV LELAND STANFORD JUNIOR·Filed 2022·Application pending·0 cites
- 4963US11972098B2Interaction signal processing in distributed computing systemsMICROSOFT TECHNOLOGY LICENSING LLC·Filed 2021·Granted Apr 30, 2024·0 cites·20 claims
- 5063US10936270B2Presentation facilitationMICROSOFT TECHNOLOGY LICENSING LLC·Filed 2016·Granted Mar 2, 2021·0 cites·20 claims
Showing the top 50 of 105 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Bo Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →